Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 4
2012 3
2013 1
2014 3
2015 3
2016 4
2017 10
2018 10
2019 14
2020 14
2021 25
2022 15
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis.
Miura S, Iwamoto H, Namba M, Yamaguchi K, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Ohshimo S, Fujitaka K, Hamada H, Hattori N. Miura S, et al. Among authors: horimasu y. BMJ Open Respir Res. 2024 Feb 20;11(1):e001803. doi: 10.1136/bmjresp-2023-001803. BMJ Open Respir Res. 2024. PMID: 38378778 Free PMC article.
Identification of kynurenine and quinolinic acid as promising serum biomarkers for drug-induced interstitial lung diseases.
Sun Y, Saito K, Ushiki A, Abe M, Saito Y, Kashiwada T, Horimasu Y, Gemma A, Tatsumi K, Hattori N, Tsushima K, Takemoto K, Ishikawa R, Momiyama T, Matsuyama SI, Arakawa N, Akane H, Toyoda T, Ogawa K, Sato M, Takamatsu K, Mori K, Nishiya T, Izumi T, Ohno Y, Saito Y, Hanaoka M. Sun Y, et al. Among authors: horimasu y. Respir Res. 2024 Jan 14;25(1):31. doi: 10.1186/s12931-023-02653-6. Respir Res. 2024. PMID: 38221627 Free PMC article.
Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis.
Oda T, Iwamoto H, Takeno S, Kawasumi T, Takemoto K, Nishida M, Chikuie N, Horibe Y, Yamaguchi K, Sakamoto S, Higaki N, Taruya T, Horimasu Y, Masuda T, Hamamoto T, Nakashima T, Ishino T, Ueda T, Fujitaka K, Hamada H, Hattori N. Oda T, et al. Among authors: horimasu y. Medicina (Kaunas). 2023 Oct 5;59(10):1776. doi: 10.3390/medicina59101776. Medicina (Kaunas). 2023. PMID: 37893494 Free PMC article.
Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases.
Nakamoto K, Horimasu Y, Yamaguchi K, Sakamoto S, Masuda T, Miyamoto S, Nakashima T, Iwamoto H, Ohshimo S, Sadamori T, Fujitaka K, Hamada H, Shime N, Hattori N. Nakamoto K, et al. Among authors: horimasu y. Intern Med. 2023 Oct 20. doi: 10.2169/internalmedicine.2387-23. Online ahead of print. Intern Med. 2023. PMID: 37866919 Free article.
Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in Japan.
Omori K, Kitagawa H, Yamaguchi K, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Tadera K, Nomura T, Shigemoto N, Aoki G, Hattori N, Ohge H. Omori K, et al. Among authors: horimasu y. J Infect Chemother. 2023 Sep;29(9):875-881. doi: 10.1016/j.jiac.2023.05.013. Epub 2023 May 19. J Infect Chemother. 2023. PMID: 37209842
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition.
Tokumo K, Masuda T, Nakashima T, Namba M, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Iwamoto H, Fujitaka K, Miyata Y, Okada M, Hamada H, Hattori N. Tokumo K, et al. Among authors: horimasu y. Cancers (Basel). 2023 Feb 8;15(4):1092. doi: 10.3390/cancers15041092. Cancers (Basel). 2023. PMID: 36831438 Free PMC article.
103 results